Stivarga 40 MG tablet 21S
Ended Awarded Last action
- Contract number
- SPE2DR26FHNU6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,939
Award facts
- Contract value 100% obligated
- $16,939.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $16,939.20 to DMS Pharmaceutical Group Inc. for 21 tablets of Stivarga 40 mg, an oncology medication used in cancer treatment. This firm fixed-price delivery order, awarded January 12, 2026, with completion targeted for January 13, 2026, represents a small but critical pharmaceutical supply requirement for Department of Defense medical operations. The order carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.9 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying pharmaceutical products to military healthcare facilities worldwide. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, holds a single-award IDC under the PPV-G GEN V program with a ceiling value of approximately $500 million and completion date of December 31, 2036. The company's established performance across numerous delivery orders demonstrates its capability to fulfill the diverse pharmaceutical and medical supply requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FHNU6?
SPE2DR26FHNU6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FHNU6 worth?
The government has obligated $16,939 on SPE2DR26FHNU6.
Is contract SPE2DR26FHNU6 an order under another contract?
Yes. SPE2DR26FHNU6 is a delivery order under SPE2DR25D9231, an indefinite delivery contract.
Was contract SPE2DR26FHNU6 competed?
The extent of competition for SPE2DR26FHNU6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award